Expression of Immuoregulators IDO1, and PD-L1 in Gastrointestinal Stromal Tumors

被引:0
|
作者
Matoso, Andres [1 ]
Siddique, Ayesha [1 ]
Lombardo, Kara A. [1 ]
Resnick, Murray B. [1 ]
Taliano, Ross [1 ]
Wang, Li J. [1 ]
机构
[1] Brown Univ, Providence, RI 02912 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
747
引用
收藏
页码:187A / 187A
页数:1
相关论文
共 50 条
  • [1] Expression of Immuoregulators IDO1, and PD-L1 in Gastrointestinal Stromal Tumors
    Matoso, Andres
    Siddique, Ayesha
    Lombardo, Kara A.
    Resnick, Murray B.
    Tahano, Ross
    Wang, Li J.
    LABORATORY INVESTIGATION, 2017, 97 : 187A - 187A
  • [2] Analysis of PD-L1 Expression in Patients with Gastrointestinal Stromal Tumors
    Abrahao, A. B. Kinupe
    Jamani, R.
    Hsieh, E.
    Ko, Y-J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients
    Toda, Yu
    Kohashi, Kenichi
    Yamada, Yuichi
    Ishihara, Shin
    Ito, Yoshihiro
    Yamamoto, Hidetaka
    Oda, Yoshinao
    CANCER SCIENCE, 2021, 112 : 514 - 514
  • [4] Immunosuppression Factors PD-1, PD-L1, and IDO1 and Colorectal Cancer
    O. V. Kovaleva
    M. A. Rashidova
    A. N. Gratchev
    V. V. Maslennikov
    I. V. Boulitcheva
    E. S. Gershtein
    E. A. Korotkova
    N. Yu. Sokolov
    V. V. Delektorskaya
    Z. Z. Mamedli
    N. E. Kushlinskii
    Doklady Biochemistry and Biophysics, 2021, 497 : 66 - 70
  • [5] Immunosuppression Factors PD-1, PD-L1, and IDO1 and Colorectal Cancer
    Kovaleva, O., V
    Rashidova, M. A.
    Gratchev, A. N.
    Maslennikov, V. V.
    Boulitcheva, I., V
    Gershtein, E. S.
    Korotkova, E. A.
    Sokolov, N. Yu
    Delektorskaya, V. V.
    Mamedli, Z. Z.
    Kushlinskii, N. E.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2021, 497 (01) : 66 - 70
  • [6] PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma
    Matthew W. Rosenbaum
    Benjamin J. Gigliotti
    Sara I. Pai
    Sareh Parangi
    Heather Wachtel
    Mari Mino-Kenudson
    Viswanath Gunda
    William C. Faquin
    Endocrine Pathology, 2018, 29 : 59 - 67
  • [7] PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma
    Rosenbaum, Matthew W.
    Gigliotti, Benjamin J.
    Pai, Sara I.
    Parangi, Sareh
    Wachtel, Heather
    Mino-Kenudson, Mari
    Gunda, Viswanath
    Faquin, William C.
    ENDOCRINE PATHOLOGY, 2018, 29 (01) : 59 - 67
  • [8] Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma
    Wu, Rui-Yan
    Kong, Peng-Fei
    Xia, Liang-Ping
    Huang, Yun
    Li, Zhi-Ling
    Tang, Yun-Yun
    Chen, Yu-Hong
    Li, Xuan
    Senthilkumar, Ravichandran
    Zhang, Hai-Liang
    Sun, Ting
    Xu, Xue-Lian
    Yu, Yan
    Mai, Jia
    Peng, Xiao-Dan
    Yang, Dong
    Zhou, Li-Huan
    Feng, Gong-Kan
    Deng, Rong
    Zhu, Xiao-Feng
    CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4530 - 4541
  • [9] Differential expression of PD-L1 and IDO1 in association with the immune microenvironment in resected lung adenocarcinomas
    Zhang, M. Lisa
    Kem, Marina
    Mooradian, Meghan J.
    Eliane, Jean-Pierre
    Huynh, Tiffany G.
    Iafrate, A. John
    Gainor, Justin F.
    Mino-Kenudson, Mari
    MODERN PATHOLOGY, 2019, 32 (04) : 511 - 523
  • [10] Clinicopathologic characterization of ocular adnexal marginal zone lymphoma with a focus on PD1, PD-L1, and IDO1 expression
    Guney, Ekin
    Pekmezci, Melike
    Bloomer, Michele
    Zoltan, Laszik
    Ohgami, Robert
    Wen, Kwun Wah
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (06): : 681 - 681